JPMorgan Chase & Co. cut shares of Reckitt Benckiser Group (OTCMKTS:RBGLY – Free Report) from an overweight rating to a neutral rating in a report published on Thursday, MarketBeat reports.
Reckitt Benckiser Group Stock Performance
Shares of RBGLY opened at $11.56 on Thursday. Reckitt Benckiser Group has a 12 month low of $10.24 and a 12 month high of $15.03. The stock’s 50-day moving average is $11.10 and its two-hundred day moving average is $11.57.
Reckitt Benckiser Group Cuts Dividend
The company also recently disclosed a dividend, which will be paid on Monday, September 23rd. Shareholders of record on Monday, August 5th will be given a $0.1915 dividend. The ex-dividend date is Monday, August 5th.
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Featured Stories
- Five stocks we like better than Reckitt Benckiser Group
- Options Trading – Understanding Strike Price
- Birkenstock’s Sudden Slide—Why It Might Be Your Next Big Win
- Insider Trading – What You Need to Know
- Veeva’s Stock Jumps on Stellar Q2 Results—Don’t Miss Out
- How to Use Stock Screeners to Find Stocks
- Why Dell Can Continue Winning in AI and Beyond
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
